[Interferon in anogenital infections with human papillomavirus]
- PMID: 8273374
[Interferon in anogenital infections with human papillomavirus]
Abstract
Interferons (IFN) provide a systemic alternative for the therapy of human papillomavirus (HPV) induced anogenital warts. Local therapy cannot totally eliminate latent viral genome in the perilesional epithelium. This causes the danger of new exacerbations. Reviewing different reports and by own therapeutic experience we think, that IFN treatment may be successful in combination with local therapy and for pre-surgical diminution of extended condyloma. Sufficient dose is necessary. Poor effects are to be expected if the warts lasted for longer than 12 months and in case of severe immunodeficiency.
Similar articles
-
Interferon treatment of anogenital human papillomavirus-related diseases.Dermatol Clin. 1991 Apr;9(2):343-52. Dermatol Clin. 1991. PMID: 1711942 Review.
-
A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.Wien Klin Wochenschr. 1996;108(2):45-7. Wien Klin Wochenschr. 1996. PMID: 8835432
-
Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions.Anticancer Res. 2002 Mar-Apr;22(2B):1171-6. Anticancer Res. 2002. PMID: 12168920
-
Interferon as an adjuvant treatment for genital condyloma acuminatum.Int J Gynaecol Obstet. 1995 May;49(2):171-4. doi: 10.1016/0020-7292(95)02339-e. Int J Gynaecol Obstet. 1995. PMID: 7649323 Clinical Trial.
-
Interferons in the treatment of genital human papillomavirus infections.Am J Med. 1988 Aug 29;85(2A):159-64. Am J Med. 1988. PMID: 3044081 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical